SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation

14 December 2021 - Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland ...

Read more →

SMC - December 2021 decisions

13 December 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has published ...

Read more →

Three cancer drugs approved for NHS use in Scotland

10 November 2021 - Three new cancer drugs have been given the go-ahead by the SMC for routine use in ...

Read more →

SMC accepts oral therapy for relapsing multiple sclerosis

10 November 2021 - Janssen has announced that the SMC have accepted Ponvory (ponesimod) within NHS Scotland, as a treatment for ...

Read more →

SMC - November 2021 decisions

8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published ...

Read more →

SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients

13 October 2021 - The SMC has recommended Cabometyx (cabozantinib) plus Opdivo (nivolumab) for use by via NHS Scotland for ...

Read more →

Scotland is first country to offer free digital therapies to every adult

13 October 2021 - The Scottish Government has announced that all Scottish adults will now have access to "digital therapeutics" ...

Read more →

SMC - October 2021 decisions

11 October 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland has today ...

Read more →

SMC - September 2021 decisions

13 September 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Scotland backs Bavencio for bladder cancer after NICE says no

9 August 2021 - Patients with bladder cancer in Scotland will be the first in the UK to claim access ...

Read more →

SMC - August 2021 decisions

9 August 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...

Read more →

Kesimpta (ofatumumab) approved for relapsing remitting MS in Scotland

12 July 2021 - The SMC has recommended that Kesimpta can be prescribed for people with relapsing remitting multiple sclerosis who ...

Read more →

Tecentriq, Kesimpta lead latest SMC decisions

13 July 2021 - The SMC has accepted three new medicines for use by NHS Scotland and rejected one in its ...

Read more →

SMC - July 2021 decisions

12 July 2021 - The SMC has today published advice accepting three new medicines. ...

Read more →

SMC - June 2021 decisions

7 June 2021 - Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia ...

Read more →